New Product Introduction

InhalationInnovation

Our proven track record takes new chemical entities (NCE) and repurposed active pharmaceutical ingredients (API) from the laboratory to market-ready MDI products. With expertise in pressurised formulation complexities and rigorous regulatory standards, we deliver stability and compliance.

Building your IP Portfolio

We craft essential IP that enhances performance, extends patent life, and secures equity for your venture, clinical endeavours, and market strategies. Our focus on formulation and device IP is backed by a history of groundbreaking MDI patents spanning three decades.

Versatile Solutions for Diverse Molecules

At OzUK, we offer the tools and expertise to develop locally acting, systemic, and scheduled drug molecules, holding licenses for a wide range of indications. Partner with us to navigate the intricate world of inhalation product development."

From concept to IND via MDISprint™